Ezio Ghigo
#117,524
Most Influential Person Now
Researcher
Ezio Ghigo's AcademicInfluence.com Rankings
Ezio Ghigophysics Degrees
Physics
#4464
World Rank
#6134
Historical Rank
Particle Physics
#187
World Rank
#200
Historical Rank

Download Badge
Physics
Ezio Ghigo's Degrees
- PhD Physics University of Turin
- Masters Physics University of Turin
- Bachelors Physics University of Turin
Why Is Ezio Ghigo Influential?
(Suggest an Edit or Addition)Ezio Ghigo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. (2004) (1194)
- Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. (2001) (732)
- Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT (2002) (729)
- A consensus on criteria for cure of acromegaly. (2010) (712)
- Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. (1998) (675)
- Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. (2001) (567)
- Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. (2007) (482)
- Growth hormone secretagogue binding sites in peripheral human tissues. (2000) (441)
- Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans (2000) (405)
- Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. (2002) (402)
- Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. (2002) (374)
- Ghrelin (2015) (371)
- Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. (2004) (365)
- Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. (2001) (349)
- Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. (2005) (343)
- Changes in Weight and Nutritional Habits in Adults with Obesity during the “Lockdown” Period Caused by the COVID-19 Virus Emergency (2020) (338)
- Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury (2004) (321)
- The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. (2005) (308)
- Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. (2007) (301)
- Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. (2005) (299)
- Neuroendocrine control of growth hormone secretion. (1999) (297)
- Extracellular vesicles as an emerging mechanism of cell-to-cell communication (2012) (297)
- Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. (1996) (288)
- Ghrelin-induced growth hormone secretion in humans. (2000) (285)
- Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. (1998) (284)
- Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. (2008) (283)
- Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. (2004) (257)
- New approach to the diagnosis of growth hormone deficiency in adults. (1996) (252)
- Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. (2000) (240)
- The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. (2003) (233)
- Consensus guidelines on screening for hypopituitarism following traumatic brain injury (2005) (231)
- Consensus statement: medical management of acromegaly. (2005) (227)
- Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. (2012) (219)
- Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. (2004) (216)
- Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. (2004) (213)
- A systematic literature review of reviews on techniques for physical activity measurement in adults: a DEDIPAC study (2018) (212)
- Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. (1999) (212)
- Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor (2005) (207)
- Obestatin Promotes Survival of Pancreatic β-Cells and Human Islets and Induces Expression of Genes Involved in the Regulation of β-Cell Mass and Function (2008) (190)
- Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. (2003) (185)
- Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (2017) (179)
- Predictors of morbidity and mortality in acromegaly: an Italian survey. (2012) (175)
- Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. (2013) (175)
- Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland (2001) (169)
- Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. (2002) (166)
- Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin. (1986) (165)
- The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. (2003) (164)
- Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. (1990) (163)
- Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. (1994) (162)
- Ghrelin drives GH secretion during fasting in man. (2002) (151)
- A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update. (2020) (151)
- Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. (1998) (141)
- Ghrelin-producing endocrine tumors of the stomach and intestine. (2001) (138)
- Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland (2001) (134)
- Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans (2003) (133)
- Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. (2003) (131)
- The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state (2004) (126)
- Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. (2003) (123)
- Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. (2001) (121)
- Dual effects of IGFBP‐3 on endothelial cell apoptosis and survival: Involvement of the sphingolipid signaling pathways (2004) (119)
- Consuming More of Daily Caloric Intake at Dinner Predisposes to Obesity. A 6-Year Population-Based Prospective Cohort Study (2014) (117)
- Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. (1999) (117)
- Hypopituitarism (2007) (116)
- The IGF system (2011) (115)
- Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term (2018) (114)
- Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood (2002) (114)
- Acetylcholine regulates ghrelin secretion in humans. (2004) (114)
- Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy. (2002) (113)
- Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. (2002) (112)
- Endocrine and metabolic responses to extreme altitude and physical exercise in climbers. (2007) (112)
- Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis. (2008) (111)
- Heterogeneity of Ghrelin/Growth Hormone Secretagogue Receptors (2007) (110)
- Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. (2008) (110)
- Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. (2000) (110)
- Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables (2003) (109)
- Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. (2003) (108)
- Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. (2003) (108)
- Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology (2014) (106)
- Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects. (1986) (106)
- Sleep abnormalities in type 2 diabetes may be associated with glycemic control (2008) (105)
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. (2009) (105)
- Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study (2015) (104)
- Insulin‐like growth factor binding protein‐3 induces angiogenesis through IGF‐I‐ and SphK1‐dependent mechanisms (2007) (102)
- The GH/IGF-I axis in obesity: influence of neuroendocrine and metabolic factors (2000) (101)
- Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling. (1998) (100)
- Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement (2015) (100)
- Comparisons among old and new provocative tests of GH secretion in 178 normal adults. (2000) (99)
- A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. (2008) (99)
- The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. (1999) (98)
- Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. (2010) (97)
- Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients (1999) (96)
- Endocrine and Non-Endocrine Actions of Ghrelin (2003) (94)
- Growth Hormone-Releasing Peptides and Their Analogs (1998) (94)
- Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. (2005) (94)
- Gender and gonadal influences on ghrelin mRNA levels in rat stomach. (2001) (93)
- Current management practices for acromegaly: an international survey (2011) (93)
- Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. (2000) (93)
- Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. (1991) (93)
- Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients (2012) (93)
- Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults (2008) (92)
- Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. (1986) (92)
- Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults (2001) (92)
- The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways (2012) (92)
- ARGININE POTENTIATES THE GHRH‐ BUT NOT THE PYRIDOSTIGMINE‐INDUCED GH SECRETION IN NORMAL SHORT CHILDREN. FURTHER EVIDENCE FOR A SOMATOSTATIN SUPPRESSING EFFECT OF ARGININE (1990) (92)
- Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood. (1996) (91)
- Obestatin regulates adipocyte function and protects against diet‐induced insulin resistance and inflammation (2012) (90)
- Effects of GHRP-2 and Hexarelin, Two Synthetic GH-Releasing Peptides, on GH, Prolactin, ACTH and Cortisol Levels in Man. Comparison with the Effects of GHRH, TRH and hCRH (1997) (89)
- Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials (2018) (89)
- The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. (1997) (88)
- Growth hormone-releasing peptides. (1997) (88)
- Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. (1997) (87)
- Metabolic and cardiovascular outcomes in patients with Cushing’s syndrome of different aetiologies during active disease and 1 year after remission (2011) (85)
- The GH‐releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans (2002) (85)
- Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor (2006) (84)
- Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. (1996) (84)
- Ghrelin secretion is inhibited by glucose load and insulin‐induced hypoglycaemia but unaffected by glucagon and arginine in humans (2004) (83)
- Neuroregulation of the Hypothalamus-Pituitary-Adrenal (HPA) Axis in Humans: Effects of GABA-, Mineralocorticoid-, and GH-Secretagogue-Receptor Modulation (2006) (83)
- Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test. (2000) (83)
- Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans (1999) (83)
- Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. (1994) (82)
- Unacylated Ghrelin Rescues Endothelial Progenitor Cell Function in Individuals With Type 2 Diabetes (2010) (81)
- Unacylated Ghrelin Promotes Skeletal Muscle Regeneration Following Hindlimb Ischemia via SOD‐2–Mediated miR‐221/222 Expression (2013) (80)
- Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. (2002) (79)
- The Antiproliferative Effect of Synthetic Peptidyl GH Secretagogues in Human CALU-1 Lung Carcinoma Cells. (2002) (79)
- Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. (2010) (79)
- Biologic activities of growth hormone secretagogues in humans (2001) (79)
- Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. (2010) (78)
- Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. (2009) (77)
- Effects of time-restricted feeding on body weight and metabolism. A systematic review and meta-analysis (2019) (77)
- Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison’s disease (2016) (77)
- Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. (1992) (76)
- Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. (1984) (76)
- Neuroendocrine Alterations in Obese Patients with Sleep Apnea Syndrome (2010) (73)
- Activity of GH/IGF‐I axis in patients with dilated cardiomyopathy (1999) (73)
- Human aging and the GH-IGF-I axis. (1996) (72)
- Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. (2012) (72)
- Unacylated Ghrelin Induces Oxidative Stress Resistance in a Glucose Intolerance and Peripheral Artery Disease Mouse Model by Restoring Endothelial Cell miR-126 Expression (2014) (72)
- Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions. (2007) (72)
- Modulation of growth hormone-releasing activity of hexarelin in man. (1995) (72)
- C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. (2012) (71)
- Effects of glucose, free fatty acids or arginine load on the GH‐releasing activity of ghrelin in humans (2002) (70)
- Diagnostic reliability of a single IGF‐I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency (2003) (70)
- Diet-Gut Microbiota Interactions and Gestational Diabetes Mellitus (GDM) (2019) (69)
- Hypopituitarism following traumatic brain injury. (2005) (69)
- Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms. (2007) (68)
- Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. (2007) (67)
- Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. (2002) (67)
- Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells. (2008) (66)
- Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations. (2005) (65)
- Diagnosis of adult GH deficiency (2008) (65)
- Diagnosis of adult GH deficiency. (2008) (65)
- Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic β -cells (2006) (64)
- Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone (2011) (63)
- Hypothalamus–pituitary–adrenal axis evaluation in patients with hypothalamo–pituitary disorders: comparison of different provocative tests (2008) (63)
- Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. (2002) (63)
- Low dose (1 μg) ACTH test in the evaluation of adrenal dysfunction in pre‐clinical Addison's disease (2000) (63)
- Growth hormone-releasing peptides and the cardiovascular system. (2000) (63)
- Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study (2017) (61)
- Role of mineralocorticoid receptors on the hypothalamus–pituitary–adrenal axis in humans (2013) (59)
- Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade. (2005) (59)
- Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults (1998) (58)
- Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. (1995) (58)
- Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism. (2001) (58)
- Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children (2006) (58)
- Marked GH secretion after ghrelin alone or combined with GH‐releasing hormone (GHRH) in obese patients (2004) (57)
- Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients (2008) (57)
- Cardiac effects of hexarelin in hypopituitary adults. (1999) (57)
- Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans. (2001) (56)
- Glucose metabolism in patients with subclinical Cushing’s syndrome (2012) (55)
- Ghrelin: endocrine, metabolic and cardiovascular actions. (2005) (55)
- Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat. (1988) (55)
- Simple lifestyle recommendations and the outcomes of gestational diabetes. A 2×2 factorial randomized trial (2014) (55)
- Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY. (2018) (55)
- Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency (1997) (54)
- Circulating ghrelin levels in the newborn are positively associated with gestational age (2004) (54)
- Hypopituitarism following traumatic brain injury (TBI): A guideline decalogue (2004) (54)
- Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function (2004) (53)
- First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group (2006) (53)
- Ghrelin secretion in childhood is refractory to the inhibitory effect of feeding. (2004) (53)
- Relationships between dehydroepiandrosterone‐sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women (1999) (52)
- Ghrelin Is No Longer Able to Stimulate Growth Hormone Secretion in Patients with Cushing’s Syndrome but Instead Induces Exaggerated Corticotropin and Cortisol Responses (2002) (52)
- Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature. (1987) (52)
- Endocrine and Non-Endocrine Activities of Growth Hormone Secretagogues in Humans (1999) (52)
- Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging. (1990) (52)
- Hypopituitarism following brain injury: when does it occur and how best to test? (2012) (51)
- Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal. (2008) (50)
- Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy. (2011) (50)
- Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. (1996) (50)
- Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI). (2004) (50)
- Des-acyl ghrelin fragments and analogues promote survival of pancreatic β-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats. (2012) (49)
- RFamide Peptides 43RFa and 26RFa Both Promote Survival of Pancreatic β-Cells and Human Pancreatic Islets but Exert Opposite Effects on Insulin Secretion (2014) (49)
- Effects of Dexamethasone and Alprazolam, a Benzodiazepine, on the Stimulatory Effect of Hexarelin, a Synthetic GHRP, on ACTH, Cortisol and GH Secretion in Humans (1998) (49)
- Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans. (1995) (48)
- Ghrelin and the endocrine pancreas (2003) (48)
- Cost-of-illness study in acromegalic patients in Italy (2004) (48)
- Benzodiazepines and anterior pituitary function (2002) (48)
- Brain–gut communication: cortistatin, somatostatin and ghrelin (2007) (48)
- Changes in awakening Cortisol response and midnight salivary Cortisol are sensitive markers of strenuous training-induced fatigue (2008) (47)
- The diagnosis of growth hormone deficiency in adults. (1997) (47)
- Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes. (2009) (47)
- Ghrelin and cortistatin in lung cancer: Expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line (2006) (47)
- Ghrelin, Hypothalamus-Pituitary-Adrenal (HPA) Axis and Cushing's Syndrome (2005) (46)
- Impact of Snacking Pattern on Overweight and Obesity Risk in a Cohort of 11- to 13-Year-Old Adolescents (2014) (46)
- Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH1−24 (2001) (46)
- Age-related Variations in the Neuroendocrine Control, More Than Impaired Receptor Sensitivity, Cause The Reduction in the GH-releasing Activity of GHRPs in Human Aging (1998) (46)
- Normal age-dependent values of serum insulin growth factor-I: Results from a healthy Italian population (2007) (46)
- Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly (2017) (46)
- Corticotroph axis sensitivity after exercise: Comparison between elite athletes and sedentary subjects (2007) (46)
- Pegvisomant in acromegaly: an update (2017) (46)
- EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man (2002) (45)
- Interaction of free fatty acids and arginine on growth hormone secretion in man. (1994) (45)
- Tall stature without growth hormone: four male patients with aromatase deficiency. (2010) (45)
- The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations. (1997) (45)
- Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. (1997) (45)
- GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. (2002) (45)
- The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans (2008) (44)
- Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours (2005) (44)
- Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans. (1999) (44)
- Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors. (2006) (44)
- Variations of Pituitary Function Over Time after Brain Injuries: The Lesson from a Prospective Study (2006) (44)
- Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children. (1989) (44)
- Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B. (2011) (43)
- Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans. (2000) (43)
- Critical assessment of the current guidelines for the management and treatment of morbidly obese patients (2007) (43)
- High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study (2017) (43)
- Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty. (1995) (42)
- Orally active growth hormone secretagogues: state of the art and clinical perspectives. (1998) (42)
- Effect of the potentiation of cholinergic activity on the variability in individual GH response to GH-releasing hormone (1989) (42)
- Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy. (2009) (42)
- Paediatric Pituitary Adenomas: A Decade of Change (2014) (42)
- GPR103b functions in the peripheral regulation of adipogenesis. (2010) (42)
- Diagnosis of GH deficiency in adults. (1998) (42)
- Ghrelin: from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions. (2006) (42)
- The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. (2002) (41)
- Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test. (1999) (41)
- Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients (1996) (41)
- Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications. (1991) (41)
- Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. (2001) (41)
- Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: An update (2010) (41)
- Insulin-Like Growth Factor I (2000) (40)
- BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease (2012) (40)
- ACROSTUDY: the Italian experience (2015) (40)
- Endocrine Function Is Altered in Chronic Migraine Patients with Medication‐Overuse (2006) (39)
- Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. (1997) (39)
- The microbiota composition of the offspring of patients with gestational diabetes mellitus (GDM) (2019) (39)
- Free fatty acids exert an inhibitory effect on adrenocorticotropin and cortisol secretion in humans. (2004) (39)
- Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma. (2006) (38)
- Ghrelin: endocrine and non-endocrine actions. (2002) (38)
- The diagnosis of growth hormone deficiency (GHD) in adults. (1995) (37)
- Pegvisomant in acromegaly: Why, when, how (2007) (37)
- Endocrine actions of cortistatin: In vivo studies (2008) (37)
- Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children. (1989) (37)
- The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans. (2002) (37)
- Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility. (2012) (37)
- 10 Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects (1998) (36)
- Neurotransmitter Control of Growth Hormone Secretion in Humans (1993) (36)
- Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects (1997) (36)
- Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging. (1996) (36)
- Growth hormone treatment in human ageing: benefits and risks (2008) (36)
- Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. (1998) (36)
- Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration (1994) (35)
- Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms (2014) (35)
- Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure (2017) (35)
- Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects (1994) (35)
- Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. (2002) (35)
- Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. (2000) (35)
- Obestatin: is it really doing something? (2014) (35)
- Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement. (2009) (35)
- Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. (1999) (35)
- Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin‐induced hypoglycaemia in humans (2003) (35)
- Endocrine responses to ghrelin in adult patients with isolated childhood‐onset growth hormone deficiency (2002) (35)
- Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency (2001) (34)
- Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing's disease. (2011) (34)
- Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes. (2006) (34)
- Growth Hormone-Releasing Peptide Hexarelin Reduces Neonatal Brain Injury and Alters Akt/Glycogen Synthase Kinase-3β Phosphorylation (2005) (34)
- Clinical challenges with calcitonin-negative medullary thyroid carcinoma (2016) (33)
- Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging. (1994) (33)
- Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa (1994) (33)
- Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients. (2013) (33)
- Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test (1999) (33)
- Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions (1998) (33)
- Retesting the childhood-onset GH-deficient patient. (2008) (33)
- Adipocyte-derived extracellular vesicles regulate survival and function of pancreatic β cells (2021) (33)
- Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of delivery (2003) (33)
- Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension. (2020) (33)
- Endocrine and metabolic actions of ghrelin. (2010) (33)
- Traumatic Brain Injury and Hypopituitarism (2005) (33)
- Hypothalamic Growth Hormone-Insulin-like Growth Factor-I Axis across the Human Life Span (2000) (33)
- Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome. (1993) (32)
- Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly (2003) (32)
- Growth hormone-inhibiting activity of cortistatin in the rat (2001) (32)
- Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans. (2004) (32)
- Both fasting‐induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity (2003) (32)
- In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose. (1995) (32)
- Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women. (1997) (32)
- Ghrelin and anterior pituitary function. (2010) (32)
- A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone (1990) (32)
- LONG‐TERM FOLLOW‐UP OF‘CURED’PROLACTINOMA PATIENTS AFTER SUCCESSFUL ADENOMECTOMY (1990) (31)
- Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity (1994) (31)
- Does use of metformin protect against cancer in Type 2 diabetes mellitus? (2012) (31)
- Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man (1997) (31)
- Age‐related growth hormone‐releasing activity of growth hormone secretagogues in humans (1997) (31)
- The IGF‐I response to very low rhGH doses is preserved in human ageing (1998) (31)
- Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view (2020) (31)
- The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans. (1999) (30)
- Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans. (2000) (30)
- Evidence for Involvement of Endogenous Somatostatin in the Galanin-Induced Growth Hormone Secretion in Children (1990) (30)
- Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity (1999) (29)
- Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women. (1993) (29)
- GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. (2013) (29)
- The nutritional control of ghrelin secretion in humans (2006) (29)
- The activity of GH/IGF-I axis in anorexia nervosa and in obesity: A comparison with normal subjects and patients with hypopituitarism or critical illness (1998) (29)
- Obestatin: A new metabolic player in the pancreas and white adipose tissue (2013) (29)
- Muscle fiber conduction slowing and decreased levels of circulating muscle proteins after short-term dexamethasone administration in healthy subjects. (2010) (29)
- Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery. (2002) (28)
- Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults. (1999) (28)
- Repeated GH-releasing hormone administration unravels different GH secretory patterns in normal adults and children. (1989) (28)
- Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man. (1992) (28)
- Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome (2015) (28)
- Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans. (2000) (28)
- GROWTH HORMONE RESPONSES TO PYRIDOSTIGMINE IN NORMAL ADULTS AND IN NORMAL AND SHORT CHILDREN (1987) (28)
- Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs (1990) (27)
- Intracoronary ghrelin infusion decreases coronary blood flow in anesthetized pigs. (2007) (27)
- Further Evidence of Cholinergic Impairment of the Neuroendocrine Control of the GH Secretion in Down’s Syndrome (1998) (27)
- Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin (2002) (27)
- Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death (2001) (27)
- The activation of somatostatinergic receptors by either somatostatin-14 or cortistatin-17 often inhibits ACTH hypersecretion in patients with Cushing's disease. (2007) (27)
- Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity? (1993) (26)
- Ghrelin and synthetic GH secretagogues. (2002) (26)
- Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine. (2000) (26)
- Presence of cortistatin in the human pancreas (2003) (26)
- Impaired taste sensation in type 2 diabetic patients without chronic complications: a case–control study (2018) (26)
- GH‐independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy (2002) (26)
- GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses. (2012) (25)
- Somatotropic function in short stature: Evaluation by integrated auxological and hormonal indices in 214 children (1993) (25)
- Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa (2005) (25)
- Insulin-Like Growth Factor I Levels and the Diagnosis of Adult Growth Hormone Deficiency (2005) (25)
- Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism. (2013) (25)
- Obestatin Enhances In Vitro Generation of Pancreatic Islets through Regulation of Developmental Pathways (2013) (25)
- SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders (2009) (25)
- Short‐term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects (2006) (25)
- Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma (2019) (25)
- Standard light breakfast inhibits circulating ghrelin level to the same extent of oral glucose load in humans, despite different impact on glucose and insulin levels (2003) (25)
- Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans (2002) (25)
- Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans. (2010) (25)
- Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences. (2004) (25)
- Occurrence of GH deficiency in adult patients who underwent neurosurgery in the hypothalamus-pituitary area for non-functioning tumour masses. (2003) (24)
- Hypothalamic-Pituitary Autoimmunity and Traumatic Brain Injury (2015) (24)
- Primary empty sella: Why and when to investigate hypothalamic-pituitary function. (2010) (24)
- Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly. (2002) (24)
- Long term treatment with oral single administration of bromocriptine in patients with hyperprolactinemia (1987) (24)
- Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man. (1992) (24)
- Involvement of Nitric Oxide in the Regulation of Growth Hormone Secretion in Dogs (2001) (24)
- Dehydroepiandrosterone, 17α‐hydroxyprogesterone and aldosterone responses to the low‐dose (1 µg) ACTH test in subjects with preclinical adrenal autoimmunity (2002) (24)
- Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology. (1993) (24)
- Effects of Alpha‐ and Beta‐Adrenergic Agonists and Antagonists on Growth Hormone Secretion in Man (1990) (24)
- ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease (2016) (23)
- Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults. (2012) (23)
- Unacylated ghrelin prevents mitochondrial dysfunction in a model of ischemia/reperfusion liver injury (2017) (23)
- Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans (2003) (23)
- Ghrelin: A Link between Eating Disorders, Obesity and Reproduction (2004) (23)
- The extremely low frequency electromagnetic stimulation selective for cancer cells elicits growth arrest through a metabolic shift. (2019) (23)
- Effects of meal timing on changes in circulating epinephrine, norepinephrine, and acylated ghrelin concentrations: a pilot study (2017) (23)
- Growth hormone secretion in Alzheimer's disease: studies with growth hormone-releasing hormone alone and combined with pyridostigmine or arginine. (1993) (23)
- In vitro and in vivo stability and pharmacokinetic profile of unacylated ghrelin (UAG) analogues. (2012) (23)
- A Critical Review on the Role of Food and Nutrition in the Energy Balance (2020) (23)
- Obestatin promotes proliferation and survival of adult hippocampal progenitors and reduces amyloid-β-induced toxicity (2016) (22)
- Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. (1995) (22)
- Short Procedure of GHRH Plus Arginine Test in Clinical Practice (2001) (22)
- Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man (1993) (22)
- Possible contraindication of spironolactone during pregnancy (1979) (22)
- Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels (1999) (22)
- Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin‐induced hypoglycaemia in humans (2004) (22)
- GH secretion is impaired in patients with primary hyperparathyroidism. (2002) (22)
- Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction (2009) (22)
- Intravenous glucose administration in fasting rats has differential effects on acylated and unacylated ghrelin in the portal and systemic circulation: a comparison between portal and peripheral concentrations in anesthetized rats. (2007) (21)
- Function of the GH/IGF-1 axis in healthy middle-aged male runners. (1996) (21)
- Pluripotent stem cells isolated from human amniotic fluid and differentiation into pancreatic β-cells (2009) (21)
- The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line. (2010) (21)
- Growth hormone response to oral clonidine test in normal and short children (1993) (21)
- Short‐term fasting in obesity fails to restore the blunted GH responsiveness to GH‐releasing hormone alone or combined with arginine (1995) (21)
- Neural Control of Growth Hormone Secretion in Aged Humans (1993) (21)
- The Role of Obestatin in Glucose and Lipid Metabolism (2013) (21)
- In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. (1997) (21)
- Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation. (2005) (20)
- Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine. (1993) (20)
- Growth Hormone Response to GHRH During Lifespan (1993) (20)
- GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections. (2007) (20)
- Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing’s disease (1999) (20)
- Growth hormone secretagogues as corticotrophin-releasing factors. (1998) (20)
- Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa (1999) (20)
- Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man (1996) (20)
- ACYLATED GHRELIN INHIBITS SPONTANEOUS LH PULSATILITY AND RESPONSIVENESS TO NALOXONE, BUT NOT THAT TO GnRH IN YOUNG MEN: EVIDENCE FOR A CENTRAL INHIBITORY ACTION OF GHRELIN ON THE GONADAL AXIS (2008) (20)
- Male sexual disturbances in liver diseases: What do we know? (2010) (19)
- Therapeutical doses of salbutamol inhibit the somatotropic responsiveness to growth hormone-releasing hormone in asthmatic children (1993) (19)
- Early Copeptin Determination Allows Prompt Diagnosis of Post-Neurosurgical Central Diabetes Insipidus (2019) (19)
- A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging (1992) (19)
- The study of spontaneous GH secretion after 36‐h fasting distinguishes between GH‐deficient and normal adults (1999) (19)
- Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiency. (2008) (19)
- Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease (2005) (19)
- Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects (2014) (18)
- Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa (1998) (18)
- Ghrelin: much more than a natural growth hormone secretagogue. (2002) (18)
- GH-Releasing Hormone Promotes Survival and Prevents TNF-α-Induced Apoptosis and Atrophy in C2C12 Myotubes. (2015) (18)
- Neuroendocrinology of the human growth hormone-insulin-like growth factor I axis during ageing. (1999) (18)
- Adrenal responsiveness to high, low and very low ACTH 1–24 doses in obesity (2000) (18)
- The growth hormone secretagogue receptor. (1999) (18)
- Neuroendocrine Control of Growth Hormone Secretion (1989) (18)
- The Mineralocorticoid Agonist Fludrocortisone Promotes Survival and Proliferation of Adult Hippocampal Progenitors (2016) (17)
- Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity. (1996) (17)
- Management of GH treatment in adult GH deficiency. (2017) (17)
- Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy (2001) (17)
- Hypopituitarism following traumatic brain injury. (2005) (17)
- Glucagon Is an ACTH Secretagogue as Effective as hCRH after Intramuscolar Administration while It Is Ineffective When Given Intravenously in Normal Subjects (2000) (17)
- Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in female primates and male/female mice. (2014) (17)
- Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction (2000) (17)
- The effectiveness of arginine + GHRH test compared with GHRH + GHRP‐6 test in diagnosing growth hormone deficiency in adults (2003) (17)
- Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of hexarelin and GHRP-2 in humans (1999) (17)
- Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. (1998) (17)
- Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man (1997) (17)
- Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH‐stimulated GH secretion in humans (1994) (17)
- Somatopause reflects age-related changes in the neural control of GH/IGF-I axis. (2005) (16)
- Ghrelin secretion in preterm neonates progressively increases and is refractory to the inhibitory effect of food intake. (2006) (16)
- Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy (2019) (16)
- Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3) (2000) (16)
- Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal aging. (1995) (16)
- Neuroendocrine and metabolic activities of ghrelin gene products (2011) (16)
- Defective regulation of prolactin secretion after successful removal of prolactinomas. (1983) (16)
- Effects of alpha- and beta-adrenergic agonists and antagonists on growth hormone secretion in man. (1990) (16)
- Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. (1995) (16)
- Hormonal diagnosis of GH hypersecretory states. (2003) (16)
- Should every patient with traumatic brain injury be referred to an endocrinologist? (2007) (16)
- Treatment with high doses of pegvisomant in 56 patients with acromegaly: experience from ACROSTUDY. (2016) (16)
- Traumatic brain injury and hypopituitarism in children and adolescents: is the problem under-estimated? (2007) (15)
- The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. (2005) (15)
- Managing patients with hypopituitarism after traumatic brain injury (2007) (15)
- DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement (2000) (15)
- Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism? (2006) (15)
- Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long‐term follow‐up and influence of baseline thyroid functional status (2018) (15)
- Prolonged treatment with N-acetylcysteine and L-arginine restores gonadal function in patients with polycystic ovary syndrome. (2009) (15)
- Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity. (1996) (15)
- GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. (1998) (15)
- Galanin reinstates the growth hormone response to repeated growth hormone‐releasing hormone administration in man (1992) (14)
- Growth hormone secretagogues : basic findings and clinical implications (1999) (14)
- Other than growth hormone neuroendocrine actions of ghrelin. (2013) (14)
- Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans. (1994) (14)
- Urinary cortisol and psychopathology in obese binge eating subjects (2014) (14)
- Failure of pyridostigmine to increase both basal and GHRH-induced GH secretion in the night. (1990) (14)
- The Regulation of Growth Hormone Secretion (1999) (14)
- Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment (2021) (14)
- Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion. (2013) (14)
- Hormones and athletic performance (2011) (14)
- Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: Different behavior patterns? (2002) (14)
- Hypopituitarism following traumatic brain injury (TBI): call for attention. (2005) (14)
- Pituitary Autoimmunity. (2017) (14)
- Treatment of acromegaly with SS analogues: Should GH and IGF-I target levels be lowered to assert a tight control of the disease? (2004) (14)
- Higher protein intake is associated with improved muscle strength in elite senior athletes. (2017) (14)
- Products of the ghrelin gene, the pancreatic β-cell and the adipocyte. (2013) (13)
- Secondary Adrenal Insufficiency: Where Is It Hidden and What Does It Look Like? (2016) (13)
- Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency. (2001) (13)
- Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine (2001) (13)
- Aging and Growth Hormone Releasing Peptides (1996) (13)
- Mediterranean Diet and SARS-COV-2 Infection: Is There Any Association? A Proof-of-Concept Study (2021) (13)
- Cushing’s syndrome is associated with sleep alterations detected by wrist actigraphy (2015) (13)
- Treatment of Acromegalic Osteopathy in Real-Life Clinical Practice: The BAAC (Bone Active drugs in ACromegaly) Study. (2020) (13)
- Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency? (2005) (13)
- Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood (2007) (13)
- Predictors of attrition from a weight loss program. A study of adult patients with obesity in a community setting (2020) (13)
- Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women (1998) (13)
- Insulin-like growth factor binding protein-3 mediates serum starvation- and doxorubicin-induced apoptosis in H9c2 cardiac cells (2003) (13)
- A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care. (2010) (13)
- Enhanced adrenocorticotrophic hormone and cortisol responses to corticotrophin-releasing hormone in central idiopathic diabetes insipidus. (1994) (13)
- Pluripotent stem cells isolated from human amniotic fluid and differentiation into pancreatic beta-cells. (2009) (13)
- Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans (2003) (13)
- Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN) (2020) (12)
- Neuroendocrine effects of citalopram infusion in anorexia nervosa (2006) (12)
- Growth Hormone Stimulation Tests in Pediatrics (2004) (12)
- Targeting the ghrelin receptor (2003) (12)
- Corticotropin-Releasing Effect of Hexarelin, a Peptidyl GH Secretagogue, in Normal Subjects Pretreated with Metyrapone or RU-486, a Glucocorticoid Receptor Antagonist, and in Patients with Addison’s Disease (1999) (12)
- Myocardial insulin-like growth factor-1 and insulin-like growth factor binding protein-3 gene expression in failing hearts harvested from patients undergoing cardiac transplantation. (2009) (12)
- Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans (2001) (12)
- Galanin positively modulates prolactin secretion in normal women (1996) (12)
- The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic–pituitary–adrenal (HPA) axis in humans (2013) (12)
- Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood. (1996) (12)
- GHRH and GH secretagogues: clinical perspectives and safety. (2004) (12)
- Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children (1993) (12)
- Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa (2000) (12)
- Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children (2000) (12)
- Pre-operative micronutrient deficiencies in patients with severe obesity candidates for bariatric surgery (2020) (12)
- The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions (2011) (12)
- Pirenzepine blunts the nocturnal growth hormone release in insulin dependent diabetes. (1987) (12)
- Growth hormone-releasing factor does not stimulate phosphoinositides breakdown in primary cultures of rat and human pituitary cells. (1986) (12)
- Endocrine activities of alexamorelin (Ala-His-d-2-methyl-Trp-Ala-Trp-d-Phe-Lys-NH2), a synthetic GH secretagogue, in humans. (2000) (12)
- The importance of investigation of pituitary function in children and adolescents following traumatic brain injury (2006) (12)
- Hypopituitaric patients with corticotropin insufficiency show marked impairment of the cortisol response to ACTH (1–24) independently of the duration of the disease (2003) (12)
- Rare diseases in clinical endocrinology: a taxonomic classification system (2015) (12)
- Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity. (2001) (12)
- The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa (2004) (12)
- Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia (1987) (12)
- Corticotrophin-releasing hormone does not inhibit growth hormone-releasing hormone-induced release of growth hormone in control subjects but is effective in patients with eating disorders. (1994) (12)
- Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase. (2019) (11)
- Growth hormone deficiency in the transition adolescent: should treatment be continued in adult life? (2001) (11)
- Cholinergic enhancement of pyridostigmine potentiates spontaneous diurnal but not nocturnal growth hormone secretion in short children. (1989) (11)
- Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas (2015) (11)
- Circulating obestatin levels in normal and Type 2 diabetic subjects (2010) (11)
- The Ghrelin System (2013) (11)
- Strategies for Reducing Salt and Sugar Intakes in Individuals at Increased Cardiometabolic Risk (2021) (11)
- Reference ranges of late-night salivary cortisol and cortisone measured by LC–MS/MS and accuracy for the diagnosis of Cushing’s syndrome (2020) (11)
- Structural and molecular adaptations to dexamethasone and unacylated ghrelin administration in skeletal muscle of the mice. (2018) (11)
- The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome. (1996) (11)
- Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group (2011) (11)
- Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system. (2001) (11)
- PROLACTIN AND TSH RESPONSES TO BOTH DOMPERIDONE AND TRH IN NORMAL AND HYPERPROLACTINAEMIC WOMEN AFTER DOPAMINE SYNTHESIS BLOCKADE (1985) (11)
- Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects (1998) (11)
- Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans. (2000) (11)
- Hormone Use and Abuse by Athletes (2011) (10)
- IGF-I levels in prepubertal and pubertal children with Down syndrome. (1998) (10)
- Effects of Alprazolam, a Benzodiazepine, on the ACTH-, GH- and PRL-Releasing Activity of Hexarelin, a Synthetic Peptidyl GH Secretagogue (GHS), in Patients with Simple Obesity and in Patients with Cushing's Disease (1999) (10)
- The GH-Releasing Effect of Hexarelin, a Synthetic Hexapeptide, in Newborns is Lower than in Young Adults (1997) (10)
- Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans. (2002) (10)
- Association of craniopharyngioma and pituitary adenoma (2013) (10)
- Aspects of neurotransmitter control of GH secretion: basic and clinical studies (1989) (10)
- There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients (2004) (10)
- [Growth hormone and lipids]. (1997) (10)
- Endocrine and Nonendocrine Actions of Ghrelin and GHS: State of the Art in Clinic Research (2003) (9)
- Fracture risk assessment in an Italian group of transgender women after gender-confirming surgery (2020) (9)
- Adrenal sensitivity to adrenocorticotropin 1-24 is reduced in patients with autoimmune polyglandular syndrome. (2004) (9)
- Natural and Synthetic Growth Hormone Secretagogues (2003) (9)
- Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. (1999) (9)
- Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis. (2021) (9)
- Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland (2001) (9)
- Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes Short Title: Effects of AG and UAG in morbid obesity (2009) (9)
- Low Hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH‐induced GH response in man (1997) (9)
- Ghrelin: more than a new frontier in neuroendocrinology. (2004) (9)
- Effects of Subcutaneous Sumatriptan on Plasma Growth Hormone Concentrations in Migraine Patients (2000) (9)
- Unacylated ghrelin ( UnAG ) induces oxidative stress resistance in a glucose intolerance mouse model and peripheral artery disease by restoring endothelial cell miR-126 expression (2014) (9)
- Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study (2020) (9)
- Acute clonidine administration potentiates spontaneous diurnal, but not nocturnal, growth hormone secretion in normal short children. (1990) (9)
- d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans (2007) (9)
- Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. (2009) (8)
- Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity (1997) (8)
- Hormone treatment in gender dysphoria (2008) (8)
- Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis (2022) (8)
- The Italian Endo-COVID-19. Our response to the emergency (2020) (8)
- Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa. (2006) (8)
- Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study (2008) (8)
- Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to snort-term fasting in acromegaly (2008) (8)
- The diagnostic accuracy of adjusted unconventional indices for adrenal vein sampling in the diagnosis of primary aldosteronism subtypes (2020) (8)
- Calcitriol Inhibits Viability and Proliferation in Human Malignant Pleural Mesothelioma Cells (2020) (8)
- Hyperprolactinemia: neuroendocrine and diagnostic aspects (1989) (8)
- Ghrelin Actions on Somatotropic and Gonadotropic Function in Humans. (2016) (8)
- Control and function of the GH-IGF-I axis in obesity. (2001) (8)
- Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism (1995) (8)
- Effects of Phenylalanine, Histidine, and Leucine on Basal and GHRH-stimulated GH Secretion and on PRL, Insulin, and Glucose Levels in Short Children. Comparison with the Effects of Arginine (1996) (8)
- Pyroglutamylated RF-amide peptide (QRFP) gene is regulated by metabolic endotoxemia. (2014) (8)
- Ankle brachial pressure index usefulness as predictor factor for coronary heart disease in diabetic patients (2007) (7)
- PEAK GH RESPONSE TO VARIOUS PROVOCATIVE STIMULI IN CHILDREN WITH NORMAL AND FAMILIAL SHORT STATURE (1993) (7)
- Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up (2016) (7)
- IGF-1 levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency. (1999) (7)
- The Cut-off Limits of Growth Hormone Response to the Insulin Tolerance Test Related to Body Mass Index for the Diagnosis of Adult Growth Hormone Deficiency (2020) (7)
- Testing pituitary function in aging individuals. (2005) (7)
- Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans (2008) (7)
- [Endocrine abnormalities in anorexia nervosa]. (2003) (7)
- GH Secretagogues in Aging (2000) (7)
- H9c2 cardiac muscle cells express all somatostatin receptor subtypes (2004) (7)
- Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands (2001) (7)
- Arginine-induced hypophosphatemia and hyperkaliemia in man. (1979) (7)
- Activity of GH/IGF-1 axis in burn patients: Comparison with normal subjects and patients with GH deficiency (2002) (7)
- Ghrelin: a new hormone with endocrine and non-endocrine activities. (2004) (7)
- Natural and Synthetic Growth Hormone Secretagogues: Endocrine and Nonendocrine Activities Suggesting Their Potential Usefulness as Anti-Aging Drug Interventions (2001) (7)
- Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children. (1990) (7)
- Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenism (2003) (7)
- Unacylated ghrelin (UAG) enhances the early insulin response to meal, improves glucose metabolism and decreases free fatty acids levels in healthy volunteers (2007) (6)
- Isoleucine-to-methionine substitution at residue 148 variant of PNPLA3 gene and metabolic outcomes in gestational diabetes. (2015) (6)
- The impact of real practice inappropriateness and devices’ inefficiency to variability in growth hormone consumption (2014) (6)
- IGFs and IGFBPs in adult growth hormone deficiency. (2005) (6)
- A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care (2010) (6)
- Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy (2018) (6)
- Morning Serum Cortisol Level Predicts Central Adrenal Insufficiency Diagnosed by Insulin Tolerance Test (2021) (6)
- Somatostatin, cortistatin and their receptors in health and disease. Foreword. (2008) (6)
- Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions (2020) (6)
- The incidence of the refeeding syndrome. A systematic review and meta-analyses of literature. (2021) (6)
- Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia (2022) (6)
- Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia (2003) (6)
- The Effects of Time-Restricted Eating on Metabolism and Gut Microbiota: A Real-Life Study (2022) (6)
- Natural and synthetic growth hormone secretagogues: do they have therapeutic potential? (2003) (6)
- The manifesto A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) study group one year later: What to keep and what to amend? (2007) (5)
- Normal IGF-I and enhanced IGFBP-3 response to very low rhGH dose in patients with dilated cardiomyopathy (2000) (5)
- What predicts the unsuccess of bariatric surgery? An observational retrospective study (2020) (5)
- Beta‐adrenergic agonism does not impair the GH response to acylated ghrelin in humans (2009) (5)
- GH response to GHRH, insulin, clonidine and arginine after GHRH pretreatment in children. (1992) (5)
- Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life (2022) (5)
- Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children. (1991) (5)
- Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. (1999) (5)
- Is HDL cholesterol protective in patients with type 2 diabetes? A retrospective population-based cohort study (2020) (5)
- ESE audit on management of Adult Growth Hormone Deficiency in clinical practice. (2020) (5)
- The effects of Clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy (1996) (5)
- Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus. (1992) (5)
- The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase. (2013) (5)
- Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children (1989) (5)
- Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity (2002) (5)
- Known and Unknown Growth Hormone Secretagogue Receptors and their Ligands (2004) (5)
- Age-related variations of the GH response to GH secretagogues in humans. (2002) (5)
- Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients (2000) (5)
- Different rebound rise in plasma prolactin during the postdopamine infusion phase in puerperal women and patients with pathological hyperprolactinemia. (1983) (5)
- Ghrelin and other gastrointestinal peptides involved in the control of food intake. (2007) (5)
- The negative GH auto-feedback in childhood: Effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children (2000) (5)
- Chapter 12 – Hormonal Activities of Growth Hormone Secretagogues (GHS) across Human Lifespan (1999) (5)
- Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience (2021) (5)
- Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia (1985) (4)
- Mycobiota composition and changes across pregnancy in patients with gestational diabetes mellitus (GDM) (2022) (4)
- Effects of cetrorelix, a GnRH-receptor antagonist, on gonadal axis in women with functional hypothalamic amenorrhea (2011) (4)
- Interaction of salbutamol and galanin on both basal and growth hormone releasing hormone-stimulated growth hormone secretion in humans (1995) (4)
- The effects of dose, nutrition, and age on hexarelin-induced anterior pituitary hormone secretion in adult patients on maintenance hemodialysis. (1999) (4)
- Primary hyperaldosteronism is associated with derangement in the regulation of the hypothalamus-pituitary-adrenal axis in humans (2007) (4)
- IGF-I levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency. (1998) (4)
- Diabetes Secondary to Endocrine and Pancreatic Disorders (2014) (4)
- Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa (2003) (4)
- Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe (2022) (4)
- Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension (1998) (4)
- The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison’s disease (2016) (4)
- Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight (2022) (4)
- Impact of Snacking Pattern on Overweight and Obesity Risk in A Cohort of 11-13-y Adolescents (4)
- Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin (2008) (4)
- Long-term treatment of acromegaly with pegvisomant (Somavert): cross-sectional observations from ACROSTUDY, a post-marketing, international, safety, surveillance study (2011) (4)
- Pituitary apoplexy in acromegaly after pituitary computed tomography: spontaneous or induced? (1986) (4)
- Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus. (1997) (4)
- GH Secretion in Prader-Labhard-Willi Syndrome: Somatotrope Responsiveness to GHRH is Enhanced by Arginine but not by Pryidostigmine (1996) (4)
- Correction: Obestatin Enhances In Vitro Generation of Pancreatic Islets through Regulation of Developmental Pathways (2013) (4)
- Further evidence against a stimulatory role of the cholinergic system on the hypothalamic pituitary adrenal axis in man (1990) (4)
- Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia. (1986) (4)
- Development and validation of a scoring system for pre-surgical and early post-surgical prediction of bariatric surgery unsuccess at 2 years (2021) (4)
- Activation of pituitary axis according to underlying critical illness and its effect on outcome. (2019) (4)
- Suppression and recovery of LH secretion by a potent and selective GnRH‐receptor antagonist peptide in healthy early follicular‐phase women are mediated via selective control of LH secretory burst mass (2003) (4)
- Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment (2020) (4)
- Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus–pituitary disease (2015) (4)
- Evaluation of GH deficiency by GHRH+arginine test and IGF-I levels in a large population of young, middle-aged and elderly patients who had undergone neurosurgery for tumor masses in the hypothalamus-pituitary area. (2002) (4)
- Dual-release Hydrocortisone in Addison's Disease - A Review of the Literature. (2014) (3)
- Prolonged treatment with N-acetylcysteine and L-arginine restores gonadal function in patients with PCO syndrome (2009) (3)
- Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans. (2008) (3)
- Human Ageing and the Growth Hormone/Insulin-Like Growth Factor-I(GH/IGF-I) Axis - The Impact of Growth Factors on Dementia (2012) (3)
- Do glucocorticoids induce addiction in humans? (2017) (3)
- Impact of Allogeneic Stem Cell Transplantation on Testicular and Sexual Function. (2021) (3)
- Non-Celiac Gluten/Wheat Sensitivity: Clinical Characteristics and Microbiota and Mycobiota Composition by Response to the Gluten Challenge Test (2021) (3)
- Methionine potentiates both basal and GHRH‐induced GH secretion in children (1997) (3)
- Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity (1996) (3)
- The Accuracy of Simple and Adjusted Aldosterone Indices for Assessing Selectivity and Lateralization of Adrenal Vein Sampling in the Diagnosis of Primary Aldosteronism Subtypes (2022) (3)
- Foreword. Glucocorticoid-induced osteoporosis. (2008) (3)
- Involvement of Brain Catecholamines and Acetylcholine in Growth Hormone Hypersecretory States (2012) (3)
- Similarity of the nocturnal profile of serum melatonin at early puberty and early adulthood. (1992) (3)
- Pyridostigmine plus GHRH is the Most Powerful Single Test of the Secretory Integrity of Somatotrophs (1988) (3)
- Growth hormone releasing activity of hexarelin in Down syndrome (1996) (3)
- Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects (2022) (3)
- Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children. (1993) (3)
- Increased frequency of impaired fasting glucose and isolated systolic hypertension in Paget’s disease of bone (2018) (3)
- Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone (2022) (3)
- Endocrinology and art. Acromegaly and goiter in the Pre-Columbian, Mesoamerican population. (2007) (3)
- Adipose Tissue Dysfunction in Obesity: Role of Mineralocorticoid Receptor (2022) (3)
- Endocrinology and art (2007) (3)
- Acute administration of alprazolam, a benzodiazepine activating GABA receptors, inhibits cortisol secretion in patients with subclinical but not overt Cushing’s syndrome (2013) (2)
- Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling (2021) (2)
- Affective temperaments and obesity: Is there an association with binge eating episodes and multiple weight cycling? (2021) (2)
- Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia (1984) (2)
- A comparison between the efficacy and safety of pegvisomant to that of octreotide LAR in patients with acromegaly (2007) (2)
- Effect of Bariatric Surgery on Survival and Hospitalizations in Patients with Severe Obesity. A Retrospective Cohort Study (2021) (2)
- PubMed search strategies for the identification of etiologic associations between hypothalamic-pituitary disorders and other medical conditions (2013) (2)
- Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests (2021) (2)
- Contents, Vol. 4, 1993 (1993) (2)
- Effect of 1-year oral cholecalciferol on a metabolic profile and blood pressure in poor-controlled type 2 diabetes mellitus: an open-label randomized controlled pilot study (2020) (2)
- Impact of refeeding syndrome on short- and medium-term all-cause mortality: a systematic review and meta-analysis. (2021) (2)
- Hypopituitarism in Adults and Children following Traumatic Brain Injury (2007) (2)
- Effect of digoxin on the somatotroph responsiveness to growth hormone‐releasing hormone (GHRH) alone or combined with arginine in normal young volunteers (2001) (2)
- Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patients (2012) (2)
- Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine. (1990) (2)
- Cortistatin: Not Simply a Natural Somatostatin Analogue (2003) (2)
- Effects of hexarelin, A synthetic GH-releasing hexapeptide, In humans (1995) (2)
- 62. Spironolactone as an antiandrogen in the therapy of female hirsutism (1979) (2)
- Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients (1997) (2)
- Function of GH/IGF-I axis in aging: Multicenter study in 152 healthy elderly subjects with different degrees of physical activity: Italian Association for Research on Brain Aging (AIRIC) Multicenter Study Group (1997) (2)
- Endocrine Responses to GH Secretagogues in Relation to Sex and Age in Humans (1999) (2)
- Association of Urine Metanephrine Levels with CardiometaBolic Risk: An Observational Retrospective Study (2021) (2)
- Correction to: Effects of time-restricted feeding on body weight and metabolism. A systematic review and meta-analysis (2020) (2)
- The IGF-I response to very low rhGH doses is preserved in human aging. (1999) (2)
- H9c2 cardiac muscle cells express insulin-like growth factor binding protein-3 (IGFBP-3). (2002) (2)
- Clinical Manifestations of Primary Hyperparathyroidism (2016) (2)
- Neuroendocrine effects of Citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans (2010) (2)
- Prolactin and TSH response to alpha-methyl-l-tyrosine in normal subjects and in women with pathological hyperprolactinemia. (1985) (2)
- Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgery. (2022) (2)
- Court dwarfs: an overview of European paintings from fifteenth to eighteenth century (2012) (2)
- Primary hyperparathyroidism and skeleton. Foreword. (2011) (2)
- Impervious peptides as growth hormone secretagogues (1999) (2)
- Predictive factors of a worse response to radioactive Iodine-I131 treatment in hyperthyroidism: outcome analysis in 424 patients. A single centre experience (2021) (2)
- Failure of cholinergic agonists and antagonists ot modify the GH response to GHRH in acromegaly (1990) (1)
- Development of a Prediction Model of Disease Activity in Support of Clinical Practice - the Acrodat Experience. (2015) (1)
- Effect of IGF-I administration on growth hormone secretion in obese subjects (2001) (1)
- Absence of alterations in plasma levels of various hypophyseal hormones after administration of cytidine-diphosphate-coline. (1982) (1)
- Hypopituitarism following Traumatic Brain Injury (2007) (1)
- Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-β-induced toxicity (2020) (1)
- Continuous glucose monitoring enhances the diagnostic value of mixed meal test in reactive hypoglycemia (2011) (1)
- Inheritance of female unexplained hirsutism. (1981) (1)
- Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV. (2022) (1)
- Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study (2022) (1)
- The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. (2022) (1)
- Trabecular Bone Score as an Index of Bone Fragility in Patients with Acromegaly: A Systematic Review and Meta-Analysis (2022) (1)
- Mary with Child and Saints — Palma il Vecchio (2013) (1)
- From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of Pheochromocytoma (2022) (1)
- A Simplified Ultrasonographic Score for the Prediction of Cytologically Suspicious Thyroid Nodules (2020) (1)
- In Patients with Obesity, Are Affective Temperaments Associated with Attrition? An Evaluation during and before the SARS-CoV-2 Pandemic (2022) (1)
- First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence (2021) (1)
- Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma (2022) (1)
- Neuroactive Drugs in Growth Disorders (1990) (1)
- Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study (2020) (1)
- Hexarelin-stimulated growth hormone secretion in patients on maintenance haemodialysis (1998) (1)
- Involvement of Brain Catecholamines and Acetylcholine in Growth Hormone Deficiency States (2012) (1)
- Identification of risk conditions for the development of adrenal disorders: how optimized PubMed search strategies makes the difference (2014) (1)
- Screening for Hypopituitarism Following Traumatic Brain Injury (TBI) (2006) (1)
- Combining growth hormone releasing hormone-arginine and synacthen testing diminishes the cortisol response. (2007) (1)
- Adrenal sensitivity to ACTH1-24 as function of age, body weight and pituitary function. (2002) (1)
- PATIENTS WITH AUTOIMMUNE DISEASES SHOWED ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION (2005) (1)
- TSH response to domperidone. (1986) (1)
- Prolactin secretion in patients with polycystic ovary syndrome. (1985) (1)
- Retrospective analysis of the ultrasound features of resected thyroid nodules (2020) (1)
- Young adults with Down's syndrome show increased corticotrope responsiveness to hCRH or hexarelin, a peptidyl GH secretagogue. (1999) (1)
- Erratum to Hypopituitarism following traumatic brain injury (TBI): A guideline decalogue (2014) (1)
- Ghrelin as a New Factor in the Central Network Controlling Appetite and Food Intake (2006) (1)
- MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis (2022) (1)
- Corrigendum to "Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism" [Growth Horm. IGF Res. 23 (4) (2013) 109-113] (2014) (1)
- Acute assessment of subjective appetite and implicated hormones after a hypnosis-induced hallucinated meal: a randomized cross-over pilot trial (2020) (1)
- Endocrinopathy-induced osteoporosis. Impact on health and economics of osteoporosis. (2010) (1)
- Pituitary computed tomography and dynamic tests of prolactin and thyrotropin secretion in 103 hyperprolactinemic patients. (1987) (1)
- A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma (2022) (1)
- Metabolic disorders and hypertension in mild primary hyperparathyroidism (2012) (1)
- Intermittent Growth Hormone‐Releasing Hormone Administration Unravels Different Growth Hormone Secretory Patterns in Normal Adults and Children (1989) (1)
- Effect of Six-Months Supplementation with Cholecalciferol on Glycemic and Blood Pressure Control in Elderly Type 2 Diabetic Patients with Vitamin D Deficiency: A Pilot Study (2018) (1)
- Mesenchymal stem cells-derived microvesicles modulate cellular immune response to islet antigen GAD in type 1 diabetes. (2012) (1)
- Ghrelin in the Regulation of GH Secretion and Other Pituitary Hormones (2011) (1)
- Saluto dei Direttori Scientifici (2012) (1)
- Väinö Myllyrinne: The World’s Tallest Acromegalic Soldier on a Postcard (2013) (1)
- GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. (1998) (1)
- Uptodate on GH/IGF-1 axis actions (2013) (1)
- Agromegaly and Goiter in the Pre-Columbian, Mesoamerican Population (2007) (1)
- The prevalence of silent acromegaly in prolactinomas is very low (2020) (1)
- Age-related variations in the growth hormone response to growth hormone secretagogues (1998) (1)
- Usefulness of insulin-like growth factor I levels in the diagnosis of growth hormone deficiency in adults (1998) (1)
- Nutritional parameters in patients with severe catabolism due to trauma or sepsis (1997) (1)
- Positive Metabolic Impact of Treatment with Pegvisomant in an Acromegalic Patient (2007) (0)
- GH and leptin secretion in humans Short-term fasting abolishes the sex-related difference in (2016) (0)
- Traumatic brain injury (TBI) and lipid profile abnormalities: study 12 months after the brain injury (2007) (0)
- EARLY ENDOCRINE DYSFUNCTION IN CRITICAL ILLNESS OF DIFFERENT AETIOLOGY (2014) (0)
- FEMALE PATIENTS WITH DOWN SYNDROME (DS) SHOW A GREATER INSULIN RESISTANCE IN COMPARISON WITH NORMAL FEMALES (NF) (2003) (0)
- Subjective and objective sleep evaluation in patients with hypo- and hyper-thyroidism (2009) (0)
- Effects of the ghrelin gene-derived peptides on adipose browning and thermogenesis (2021) (0)
- Endocrinopathy-induced osteoporosis. Fourth National Meeting, Ancona, Italy, September 25-26, 2008. (2009) (0)
- Society for Endocrinology European Medal Lecture (2003) (0)
- Steroidomic approach for the characterization of patients with non-alcoholic fatty liver disease (2022) (0)
- The GH response to GHRH in normal adults is not affected by enalapril or furosemide while is blunted by digoxin. (1999) (0)
- Obestatin exerts post-conditioning-like cardioprotective effects via nitrosative/oxidative signaling (2015) (0)
- AENDO June 39/6 (1999) (0)
- Idiopathic primary hyperaldosteronism frequently undergoes spontaneous remission: frequence and predictors (2012) (0)
- SUN-LB079 Acrostudy - Safety And Treatment Outcomes In 2221 Patients With Acromegaly Treated With Pegvisomant: Real World Experience (2019) (0)
- Biliary stone disease in acromegaly under somatostatinanalogues: A longterm safety study (2020) (0)
- Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma (2023) (0)
- Introduction (2009) (0)
- Ghrelin: a neuroendocrine and/or a metabolic story? (2011) (0)
- Giovanni Faglia (1930–2012) (2012) (0)
- NEW MECHANISMS IN THE CONTROL OF GROWTH HORMONE SECRETION (2003) (0)
- HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION (2005) (0)
- Glucocorticoid receptor polymorphisms and metabolic-cardiovascular impairment in adult patients with Addison's disease under glucocorticoid replacement therapy (2010) (0)
- Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21‑hydroxylase deficiency in Europe (2021) (0)
- QRFP induces β-cell and human islet cell survival and insulin secretion and promotes glucose uptake in β-cells, adipocytes and muscle cells (2009) (0)
- “Cured” Prolactinoma Patients After Transsphenoidal Adenomectomy: Prediction of Recurrence (1989) (0)
- Muscle fiber conduction slowing is a sensitive marker of steroid myopathy in Cushing’s disease (2011) (0)
- Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma (2022) (0)
- Activity of GH/IGF-I axis in catabolic patients with sepsis or trauma (1997) (0)
- Ghrelin inhibits LH pulsatile secretion in humans. (2006) (0)
- Prevalence, type and evolution of autoimmune diseases with respect to hormone control in patients with cortisol, GH and prolactin hypersecretion (2022) (0)
- GHRELIN AND SYNTHETIC GHS (2003) (0)
- Thyroid nodule ultrasound: which indication for FNA? a prospective study (2016) (0)
- Dehydroepiandrosterone positively affects nitric oxide production in platelets of normal subjects. (2006) (0)
- Early detection of antipituitary antibodies and pituitary dysfunction in patients with severe traumatic brain injury (2013) (0)
- Growth Hormone-Releasing Hormone (GHRH) exerts protective effects on adult rat hippocampal progenitor cells (2007) (0)
- Abstract #1403093: Absence of QT Prolongation Associated with Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Cushing Syndrome (2023) (0)
- SOMATOSTATIN, SOMATOSTATIN ANALOGUES AND CORTISTATIN REDUCE PDGF-INDUCED ENDOMETRIAL CELL PROLIFERATION AND MOTILITY (2009) (0)
- Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension (2020) (0)
- THE INHIBITORY EFFECT OF BETA 2ADRENORECEPTOR ACTIVATION BY SALBUTAMOL ON GH SECRETION IS AGE-DEPENDENT (1995) (0)
- Ghrelin exerts an inhibitory modulation on LH pulsatility in humans. (2006) (0)
- Effects of CST-8, a synthetic cortistatin analogue, in humans (2007) (0)
- Metabolic and cardiovascular profile in adult patients with addison's disease under conventional glucocorticoid replacement therapy (2008) (0)
- P.6.034 Endocrine responses to ghrelin in patients with eating disorders (2003) (0)
- Cortisol and dexamethasone exert different negative feedback action in humans (2007) (0)
- IGF1 levels as predictor factor of metabolic derangement in adult patients with severe GH deficiency (2010) (0)
- Effect of acipimox, an antilipolytic substance, on GH secretion in obesity (1995) (0)
- Subject Index Vol. 43, 1986 (1986) (0)
- Growth hormone-releasing hormone (GHRH) antagonists increase the sensitivity to radiotherapy in lung cancer cells (2020) (0)
- Ghrelin: what do we know about its role in health and disease? (2006) (0)
- Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension (2023) (0)
- Hypothalamic-Pituitary Diseases (2018) (0)
- Acute effects of acylated ghrelin on salbutamol-induced metabolic actions in humans (2015) (0)
- Endometriotic cell proliferation and survival are inhibited by somatostatin analogues and GHRH antagonists (2008) (0)
- Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgery (2022) (0)
- EFFECT OF hCRH, VASOPRESSIN, ALPRAZOLAM AND DEXAMETHASONE ON THE ACTH AND CORTISOL RESPONSES TO HEXARELIN, A SYNTHETIC GHRP, IN HUMANS (1997) (0)
- Subject Index Vol. 67, Suppl. 1, 2007 (2007) (0)
- Basal and stimulated GH secretion in Cushing's syndrome: effects of ghrelin and GHRH+arginine (2010) (0)
- Sensitivity and specificity of different provocative tests for the diagnosis of secondary hypoadrenalism in patients with hypothalamo-pituitary disorders (2006) (0)
- Growth hormone-releasing hormone prevents cardiomyocyte apoptosis and activated PI3K/AKT, ERK1/2 and CREB signaling pathways (2007) (0)
- Foreword (2008) (0)
- GH and cortisol secretion in patients with burn on day 7 after thermal injury (2000) (0)
- Efficacy and safety of long-term high doses of cabergoline in prolactin secreting tumor (2022) (0)
- Franco Camanni (1930–2019) (2019) (0)
- Body Weight Regulation and Hypothalamic Neuropeptides (2006) (0)
- Contents, Vol. 63, 1996 (1996) (0)
- Criteria for disease control in acromegaly under SSA treatment: mean GH profile or GH random? (2015) (0)
- P.8.050 Neuroendocrine response to intravenous citalopram infusion in anorexia nervosa (2005) (0)
- Response to the letter: ‘Octanoylated and nonoctanoylated ghrelin levels in cord blood’ by S. Ferrero (2004) (0)
- growth and adaptation Mechanical signal transduction in skeletal muscle (2015) (0)
- unacylated ghrelin recovers neovascularization in diabetes by targeting enos and redox signalling (2009) (0)
- in cells autophagy: steady- state and real-time hyperpolarized (2019) (0)
- Antagonist of growth hormone-releasing hormone (GHRH) potentiates the antitumor effect of chemotherapy in human malignant pleural mesothelioma (2022) (0)
- Ghrelin and its Analogues: Perspectives for a Story of Reverse Pharmacology (2004) (0)
- Acute effects of a hallucinatory meal on subjective appetite and food intake: A randomized cross-over pilot trial (2019) (0)
- METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION (2010) (0)
- A New Role for GPR103b in the Peripheral Regulation of Adipogenesis (2010) (0)
- Metabolic and cardiovascular parameters in adult patients with Turner’s syndrome (2010) (0)
- Prevalence of silent acromegaly in prolactinomas (PASP): an Italian experience (2019) (0)
- First and second day cortisol levels as predictors of long-term hypocortisolism after pituitary surgery (2019) (0)
- Long-Term Efficacy of Intensive Zoledronate Therapy and Predictors of Retreatment in Paget’s Disease of Bone (2021) (0)
- High-dose octreotide LAR in patients with acromegaly inadequately controlled by conventional somatostatin analogue therapy: a randomized, controlled trial (2009) (0)
- The GH releasing activity of ghrelin is insensitive to the negative growth hormone (GH) autofeedback in humans (2007) (0)
- HYPOTHALAMO-PITUITARY-ADRENAL HYPERACTIVITY IN HUMAN AGING IS FURTHER ENHANCED BY MINERALCORTICOID ANTAGONISTS (2005) (0)
- Analysis of cardiovascular comorbidities and events in a cohort of transgender people during GAHT (2022) (0)
- Front & Back Matter (2013) (0)
- Gender-affirming hormone treatment: friend or foe? Long term follow-up of 755 transgender and gender diverse people (2023) (0)
- Effects of the ghrelin gene products on glucose metabolism in C2C12 muscle cells (2011) (0)
- Session IV. Regulation of growth hormone and insulin-like growth factor I secretion : cholinergic enhancement potentiates growth hormone secretion by clonidine and L-dopa, but not arginine and galanin (1990) (0)
- Wrist actigraphy detects sleep disorders in patients with Cushing's syndrome (2012) (0)
- Simultaneous Measurement of Cortisol, Cortisone, Dexamethasone and Additional Exogenous Corticosteroids by Rapid and Sensitive LC–MS/MS Analysis (2022) (0)
- EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA (2007) (0)
- Diagnostic and therapeutic aspects of GH deficiency (GHD) in the transition period (2002) (0)
- Potential risk factors for post-treatment recurrence in patients with intermediate-risk differentiated thyroid carcinoma (2022) (0)
- Impairment of GH secretion by ghrelin stimulation test in primary hyperparathyroidism (PHP) (2007) (0)
- FRI0499 ACROMEGALY ARTROPATHY: IS THERE SOMETHING MORE BEHIND THE PAIN? A CROSS-SECTIONAL STUDY TO EVALUATE RHEUMATIC DISEASE IN GROWTH HORMONE SECRETING TUMOR PATIENTS (2020) (0)
- The effects of the acute administration of alprazolam, a benzodiazepine, in patients with subclinical Cushing's syndrome (2012) (0)
- Effects on glucose metabolism of high-dose octreotide LAR in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy (2010) (0)
- Neuroendocrine function is altered in patients with chronic migraine and medication-overuse headache (2005) (0)
- Does clinical status correlate with the severity of GH deficiency (GHD) in adults (1998) (0)
- Thyrotoxicosis is coupled with quantitative and qualitative sleep disruptions (2006) (0)
- ROLE OF AUTOPHAGY IN THE SURVIVAL EFFECT OF ACYLATED GHRELIN, UNACYLATED GHRELIN AND OBESTATIN IN HIT-15 AND INS1-E PANCREATIC β-CELLS (2009) (0)
- Hormonal, metabolic and bone evaluation in a series of adrenal incidentalomas (2008) (0)
- Growth hormone-releasing hormone (GHRH) antagonists, MIA-602 and MIA-690, inhibit survival and proliferation of human pleural mesothelioma cells (2017) (0)
- Table of Contents (2011) (0)
- QRFP43 and its fragment 26RFa both promote β-cell survival but differently regulate insulin secretion and glucose uptake in pancreatic β-cells and human pancreatic islets (2012) (0)
- An observational retrospective study on the association of urine metanephrine levels with cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma (2022) (0)
- OR7,4 The somatotroph response to acylated ghrelin is refractory to the negative GH auto-feedback, but is sensitive to negative IGF-I feedback in man (2008) (0)
- Copeptin assessment to predict vasoplegia after cardiopulmonary by-pass. An observational cohort study. (2020) (0)
- Effect of ghrelin on anterior pituitary function in patients with anorexia nervosa (2002) (0)
- The GH response to ghrelin in humans is impaired in conditions of hyper- and hypothyroidism (2006) (0)
- EVALUATION OF BASAL AND STIMULATED ACTIVITY OF THE HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM (2003) (0)
- Adult Clinical Case Sessions (2007) (0)
- Impact of Surgery or Medical Treatment with the Selective Glucocorticoid Receptor Modulator Relacorilant on Hypercoagulopathy in Patients with Cushing Syndrome (2023) (0)
- Role of GPR103b, a new G-protein coupled receptor, in the peripheral regulation of adipogenesis (2010) (0)
- Mediated miR − 2 − SOD Unacylated Ghrelin Promotes Skeletal Muscle Regeneration Following Hindlimb Ischemia via Online (2013) (0)
- Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review (2023) (0)
- Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study (2023) (0)
- WRIST ACTIGRAPHY REVEALS SLEEP DISTURBANCES IN PATIENTS WITH CUSHING’S DISEASE (2007) (0)
- P-033. GH and IGF-I levels in catabolic patients with sepsis or trauma (1997) (0)
- PPT1 COST-OF-ILLNESS STUDY IN ACROMEGALIC PATIENTS IN ITALY (2004) (0)
- Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-[beta]-induced toxicity (2022) (0)
- PATIENTS WITH AUTOIMMUNE DISEASES SHOW IMPAIRED ADRENAL SENSITIVITY TO ACTH 1-24 BUT ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION (2004) (0)
- Psychiatric disorders and anger in patients with controlled acromegaly. (2023) (0)
- The cardiometabolic risk in patients with non-functioning adrenal incidentaloma: an observational, retrospective and propensity score matched study (2023) (0)
- Subject Index Vol. 66, 1997 (1997) (0)
- Welcome to 6th Annual European Meeting on the Management of Acromegaly (2015) (0)
- Growth hormone deficiency in a case of septo-optic-dysplasia due to SOX2 mutation: should we re-test patients during the transition period? (2022) (0)
- WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY (2006) (0)
- Obestatin inhibits high glucose-induced reactive oxygen species production and apoptosis in bovine aortic endothelial cells (2008) (0)
- SIE, SIAMS, SIEDP, SIO, AIT, AME Informano (2011) (0)
- A pharmaceutical composition for intranasal administration (1988) (0)
- Effect of hexarelin on growth hormone secretion in Down syndrome (1996) (0)
- Subject Index Vol. 4, 1993 (1993) (0)
- Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in primates and mice (2012) (0)
- Subject Index Vol. 63, 1996 (1996) (0)
- Comprar Hormone Use And Abuse By Athletes | Ezio Ghigo | 9781441970138 | Springer (2010) (0)
- Polycystic Ovary Syndrome - ReadingSample (2015) (0)
- GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY (2011) (0)
- Vasopressin and CTproAVP in pathogenetic conditions Diabetes insipidus (2014) (0)
- Hypopituitarism is a Common Neuro-Endocrine Disease: How Manage to Inform the Medical Community (2006) (0)
- Basal and stimulated GH secretion in active cushing's syndrome and 2 years after remission (2012) (0)
- Motor Performance and Muscle Mass as a Function of Hormonal Responses to Exercise (2011) (0)
- Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test (2022) (0)
- Correction to: Pegvisomant in acromegaly: an update (2017) (0)
- Comparison between cortisol’s and dexamethasone’s negative feedback action in humans:evidence for preferential sensitivity to the natural glucocorticoid (2013) (0)
- The accuracy of adjusted unconventional indices for the assessment of selectivity and lateralization of adrenal vein sampling in the subtype diagnosis of primary aldosteronism (2022) (0)
- EFFECT OF HEXARELIN, A SYNTHETIC GHRP, AND/OR hCRH ON ACTH- AND CORTISOL SECRETION IN NORMAL SUBJECTS AND IN PATIENTS WITH CUSHING’S SYNDROME (1997) (0)
- Prognostic value of endocrine biomarkers in patients admitted to intensive care unit for COVID-19 (2022) (0)
- Long-term pegvisomant treatment in acromegaly (2007) (0)
- Dehydroepiandrosterone sulphate levels inpatients with hypopituitarism and severe growth hormone (GH) deficiency: Comparison with insulin-like growth factor I levels before and during GH replacement (1999) (0)
- Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH–and GH-secreting pituitary neuroendocrine tumor (PitNETs) cell lines (2021) (0)
- INTERACTION OF HYPOGLYCEMIA WITH PYRIDOSTIGMINE OR ARGININE ON GH SECRETION IN NORMAL SHORT CHILDREN (1995) (0)
- Contents Vol. 76, 2002 (2002) (0)
- Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans / R. Berardelli; (0)
- Physiological Roles of Des-Acyl Ghrelin (2012) (0)
- EVALUATION OF BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) ACTIVITY IN PRIMARY HYPERALDOSTERONISM (2004) (0)
- T09-P-04 Efficacy of ED treatment with PDE5-inhibitors in the Italian real clinical practice contest: longitudinal data from the EDOS study (2008) (0)
- The cut-off limits of GH response to GHRH + arginine test related to body mass index for the diagnosis of adult GH deficiency: do we need to review our diagnostic criteria? (2022) (0)
- Use of growth hormone-releasing materials and their antagonists for treatment of tumors (1999) (0)
- Shlomo Melmed: The Pituitary (2012) (0)
- Long-term treatment with pegvisomant (Somavert®): Observations from 2090 acromegaly patients followed in ACROSTUDY (2017) (0)
- Growth hormone releasing peptides/secretagogues (2007) (0)
- Diabetogenic effects of a continuous infusion of acylated ghrelin in normal and type 2 diabetic patients (2008) (0)
- T-28 Hypothalamic-pituitary-adrenal axis and adrenal dysfunction in non-septic cirrhotic patients with ascites: a pathophysiological and clinical evaluation (2013) (0)
- Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH and GH-secreting pituitary adenoma cell lines (2019) (0)
- Ghrelin effects on spontaneous and stimulated LH secretion in human males (2007) (0)
- Management of Growth Hormone Deficiency in Children Irradiated for Brain Tumours (2015) (0)
- Growth Hormone, Growth Hormone Releasing Peptides (1998) (0)
- Obestatin and ghrelin inhibit apoptosis of human pancreatic islet endothelial cells in high glucose culture (2010) (0)
- Predictivity of ultrasonography (US) features in evaluation of malignancy in the solitary thyroid nodule. (2005) (0)
- CHAPTER 26 – Hormones and Athletic Performance (2016) (0)
- Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice. (2023) (0)
- Erratum to: Shlomo Melmed: The Pituitary (2012) (0)
- Secondary Diabetes: Clinical Considerations (2014) (0)
- Post-Surgical Indications to Radioiodine Treatment and Potential Risk Factors for Post-Treatment Recurrence in Patients with Intermediate-Risk Differentiated Thyroid Carcinoma (2023) (0)
- Microalbuminuria as well as insulin sensitivity are improved under octreotide-lar treatment in acromegalic patients (2006) (0)
- Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes. (2022) (0)
- Primary aldosteronism is very frequent in resistant hypertension and is associated to early renal vascular damage (2012) (0)
- P-53 The pre-treatment with acylated ghrelin abolishes the GH response to GHRH and inhibits that to GHRH+ARGININE and ghrelin itself (2008) (0)
- Energy status and glucocorticoid excess (2013) (0)
- IGF-I response to short-term administration of low RHGH dose as function of sex, age and pathophysiological conditions (1998) (0)
- GHRELIN AND SYNTHETIC GROWTH HORMONE SECRETAGOGUES: ENDOCRINE AND NON-ENDOCRINE ACTIONS (2002) (0)
- GH but not IGF-I hypersecretion in acromegaly is generally attenuated in elderly acromegalics. (2002) (0)
- How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients. (2023) (0)
- SIE, SIAMS, SIEDP, SIO, AIT, AME Informano (2012) (0)
- Treatment of acromegalic osteopathy in the real-life clinical practice: The baac (bone active drugs in acromegaly) multicenter study (2020) (0)
- The Role of Neurotransmitters in Growth Hormone Secretion (1988) (0)
- NON-acylated ghrelin AS A THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISEASES (2008) (0)
- Surveillance study on the prevalence of manifestations, complications and illness associated to acromegaly (2012) (0)
- Subject Index Vol. 76, 2002 (2002) (0)
- Association between the circadian rhythm and the inhibitory effect of glucocorticoids on browning of adipocytes (2020) (0)
- Is HDL cholesterol protective in patients with type 2 diabetes? A retrospective population-based cohort study (2020) (0)
- HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS SENSITIVITY TO THE NEGATIVE FEED-BACK ACTION OF CORTISOL IN HUMANS (2003) (0)
- Erratum: Hypopituitarism following traumatic brain injury (TBI): A guideline Decalogue (Journal of Endocrinological Investigation (2004) 27, 8 (793)) (2005) (0)
- Effects of mineralocorticoid agonists and antagonists on survival, proliferation and differentiation of adult rat hippocampal progenitor cells (2012) (0)
- [Neuroregulation of GH secretion in aging]. (1993) (0)
- Adrenocortical, somatotropic and antidiuretic response to nasal glucagon in healthy subjects. (2023) (0)
- No feedback inhibition of obestatin during acylated ghrelin infusion in humans (2008) (0)
- LETTER TO THE EDITORS (1986) (0)
- Growth hormone deficiency in succesfully treated acromegalic patients is not protective from cardiac complications (2007) (0)
- Ghrelin as new provocative test for the diagnosis of GH deficiency in adults (2009) (0)
- Efficacy and safety of long-term treatment with pegvisomant in acromegaly: Italian pegvisomant observational study (ACROSTUDY) (2012) (0)
- P9 Ghrelin test: a new tool for the diagnosis of GH deficiency in adults (2010) (0)
- THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS (2010) (0)
- Growth hormone-releasing hormone (GHRH)induces cardioprotection in isolated heart akin to ischemic postconditioning (2010) (0)
- The evaluation of metabolic effects following ghrelin and salbutamol administration (2009) (0)
- Subject Index Vol. 71, Suppl. 1, 2009 (2009) (0)
- L’ipopituitarismo post trauma cranico: dall’età pediatrica all’età adulta (2012) (0)
- Effects of obestatin on proliferation and survival of adult rat hippocampal progenitor cells (2012) (0)
- Combining GHRH/Arginine with a synacthen test diminishes the cortisol response (2006) (0)
- Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy (2022) (0)
- Sarcopenia in Endocrine Disorders – The Iceberg or Its Tip? (2015) (0)
- Regulation of obestatin levels during unacylated ghrelin infusions in normal and type 2 diabetic patients (2009) (0)
- MINERALCORTICOID RECEPTOR BLOCKADE ENHANCES THE ACTIVITY OF HYPOTHALAMUS-PITUITARY-ADRENAL AXIS IN HUMANS (2000) (0)
- The story of a meeting (2008) (0)
- FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON ’ S DISEASE (2016) (0)
- Time dependency of somatotroph dysfunction following radiation damage of the hypothalamic-pituitary axis (2002) (0)
- ACTIVITY OF GH/IGF‐I AXIS IN CATABOLIC PATIENTS WITH SEPSIS OR TRAUMA: 617 (1997) (0)
- Obestatin promotes glut-4 translocation and glucose uptake in 3T3-L1 adipocytes and inhibits lipolysis in 3T3-L1 and human visceral and subcutaneous adipocytes (2009) (0)
- Front & Back Matter (2014) (0)
- Conventional glucocorticoid replacement therapy in patients with Addisons disease: effects on metabolic and bone parameters (2007) (0)
- Subject Index Vol. 68, Suppl. 5, 2007 (2007) (0)
- LB02.08: PREDICTORS OF RECURRENCE OF PHEOCHROMOCYTOMAS/PARAGANGLIOMAS PRELIMINARY DATA FROM A RETROSPECTIVE MULTICENTER STUDY IN PIEDMONT (2015) (0)
- GHRELIN IN HUMANS (2012) (0)
- The GH response to ghrelin in humans is reduced in conditions of hyper- and hypothyroidism (2006) (0)
- Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials (2018) (0)
- Glucocorticoids enhance browning and thermogenic functions of mouse and human white adipocytes (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ezio Ghigo?
Ezio Ghigo is affiliated with the following schools: